Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO
Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
A phase 2, multicenter, randomized, active-controlled, masked, parallel arm study designed to
evaluate the safety and efficacy of a single suprachoroidal injection of CLS-TA,
triamcinolone acetonide injectable suspension, given along with an intravitreal (IVT)
injection of aflibercept compared to IVT aflibercept alone in subjects with retinal vein
occlusion (RVO).